Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Syed Haider

Showing results (171-180 of 210) with videos related to

Pageof 21
Sort By:
Molecular Cancer Research : MCR|March 20, 2019
Adaptation to HIF1α Deletion in Hypoxic Cancer Cells by Upregulation of GLUT14 and Creatine MetabolismAlessandro Valli, Matteo Morotti, Christos E Zois, et al.
Nature Communications|October 30, 2014
Hypoxia promotes stem cell phenotypes and poor prognosis through epigenetic regulation of DICERTwan van den Beucken, Elizabeth Koch, Kenneth Chu, et al.
Cancers|August 7, 2021
Quantitative Assessment and Prognostic Associations of the Immune Landscape in Ovarian Clear Cell CarcinomaSaira Khalique, Sarah Nash, David Mansfield, et al.
The Journal of Pathology|July 2, 2019
The integrin αvβ6 drives pancreatic cancer through diverse mechanisms and represents an effective target for therapyClaire S Reader, Sabari Vallath, Colin W Steele, et al.
BMJ Open|June 1, 2022
Hydroxychloroquine plus personal protective equipment versus personal protective equipment alone for the prevention of laboratory-confirmed COVID-19 infections among healthcare workers: a multicentre, parallel-group randomised controlled trial from IndiaBharath Kumar Tirupakuzhi Vijayaraghavan, Vivekanand Jha, Dorrilyn Rajbhandari, et al.
British Journal of Cancer|December 11, 2019
Transcriptomic analysis of human primary breast cancer identifies fatty acid oxidation as a target for metforminSimon R Lord, Jennifer M Collins, Wei-Chen Cheng, et al.
Molecular Cancer Therapeutics|November 15, 2017
Evaluation of CDK12 Protein Expression as a Potential Novel Biomarker for DNA Damage Response-Targeted Therapies in Breast CancerKalnisha Naidoo, Patty T Wai, Sarah L Maguire, et al.
Nature Communications|February 1, 2018
RASSF1A uncouples Wnt from Hippo signalling and promotes YAP mediated differentiation via p73Angelos Papaspyropoulos, Leanne Bradley, Asmita Thapa, et al.
Nature|September 10, 2020
Targeting TRIM37-driven centrosome dysfunction in 17q23-amplified breast cancerZhong Y Yeow, Bramwell G Lambrus, Rebecca Marlow, et al.
Journal of Experimental & Clinical Cancer Research : CR|May 9, 2021
Interferon- and STING-independent induction of type I interferon stimulated genes during fractionated irradiationRuben S A Goedegebuure, Esther A Kleibeuker, Francesca M Buffa, et al.
Pageof 21

Showing results (171-180 of 210) with videos related to

Sort By:
Pageof 21
Molecular Cancer Research : MCR|March 20, 2019
Adaptation to HIF1α Deletion in Hypoxic Cancer Cells by Upregulation of GLUT14 and Creatine MetabolismAlessandro Valli, Matteo Morotti, Christos E Zois, et al.
Nature Communications|October 30, 2014
Hypoxia promotes stem cell phenotypes and poor prognosis through epigenetic regulation of DICERTwan van den Beucken, Elizabeth Koch, Kenneth Chu, et al.
Cancers|August 7, 2021
Quantitative Assessment and Prognostic Associations of the Immune Landscape in Ovarian Clear Cell CarcinomaSaira Khalique, Sarah Nash, David Mansfield, et al.
The Journal of Pathology|July 2, 2019
The integrin αvβ6 drives pancreatic cancer through diverse mechanisms and represents an effective target for therapyClaire S Reader, Sabari Vallath, Colin W Steele, et al.
BMJ Open|June 1, 2022
Hydroxychloroquine plus personal protective equipment versus personal protective equipment alone for the prevention of laboratory-confirmed COVID-19 infections among healthcare workers: a multicentre, parallel-group randomised controlled trial from IndiaBharath Kumar Tirupakuzhi Vijayaraghavan, Vivekanand Jha, Dorrilyn Rajbhandari, et al.
British Journal of Cancer|December 11, 2019
Transcriptomic analysis of human primary breast cancer identifies fatty acid oxidation as a target for metforminSimon R Lord, Jennifer M Collins, Wei-Chen Cheng, et al.
Molecular Cancer Therapeutics|November 15, 2017
Evaluation of CDK12 Protein Expression as a Potential Novel Biomarker for DNA Damage Response-Targeted Therapies in Breast CancerKalnisha Naidoo, Patty T Wai, Sarah L Maguire, et al.
Nature Communications|February 1, 2018
RASSF1A uncouples Wnt from Hippo signalling and promotes YAP mediated differentiation via p73Angelos Papaspyropoulos, Leanne Bradley, Asmita Thapa, et al.
Nature|September 10, 2020
Targeting TRIM37-driven centrosome dysfunction in 17q23-amplified breast cancerZhong Y Yeow, Bramwell G Lambrus, Rebecca Marlow, et al.
Journal of Experimental & Clinical Cancer Research : CR|May 9, 2021
Interferon- and STING-independent induction of type I interferon stimulated genes during fractionated irradiationRuben S A Goedegebuure, Esther A Kleibeuker, Francesca M Buffa, et al.
Pageof 21